The 26 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 188.00, with a high estimate of 205.00 and a low estimate of 134.00. The median estimate represents a +26.28% increase from the last price of 148.88.
The current consensus among 30 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.78
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.